everlinQ Endovascular Access Systems Enhancements (EASE-2) Study

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

December 12, 2018

Study Completion Date

December 12, 2018

Conditions
Chronic Kidney Diseases
Interventions
DEVICE

everlinQ endoAVF System

The everlinQ device is a single-use disposable device. The everlinQ catheter system consists of two flexible, magnetic catheters. Once the catheters are properly inserted and aligned, the magnets contained in each catheter attract to one another, approximating the vessels while simultaneously aligning the electrode with the backstop. Radiofrequency (RF) energy is delivered to the electrode whereby the arterio-venous fistula (AVF) is created.

Trial Locations (1)

Unknown

Sanatorio Italiano, Asunción

All Listed Sponsors
lead

TVA Medical Inc.

INDUSTRY

NCT03708562 - everlinQ Endovascular Access Systems Enhancements (EASE-2) Study | Biotech Hunter | Biotech Hunter